Whole exome sequencing is an efficient, sensitive and specific method of mutation detection in osteogenesis imperfecta and Marfan syndrome.

A. McInerney-Leo,M. Marshall,B. Gardiner,P. Coucke,L. Van Laer,B. Loeys,K. Summers,S. Symoens,J. West,M. West,B. Paul Wordsworth,A. Zankl,P. Leo,M. Brown,E. Duncan

DOI: https://doi.org/10.1038/bonekey.2013.190

2013-12-04

BoneKEy Reports

Abstract:

What problem does this paper attempt to address?

Web-based design and analysis tools for CRISPR base editing

Gue-Ho Hwang,Jeongbin Park,Kayeong Lim,Sunghyun Kim,Jihyeon Yu,Eunchong Yu,Sang-Tae Kim,Roland Eils,Jin-Soo Kim,Sangsu Bae

DOI: https://doi.org/10.1186/s12859-018-2585-4

IF: 3.307

2018-12-01

BMC Bioinformatics

Abstract:BackgroundAs a result of its simplicity and high efficiency, the CRISPR-Cas system has been widely used as a genome editing tool. Recently, CRISPR base editors, which consist of deactivated Cas9 (dCas9) or Cas9 nickase (nCas9) linked with a cytidine or a guanine deaminase, have been developed. Base editing tools will be very useful for gene correction because they can produce highly specific DNA substitutions without the introduction of any donor DNA, but dedicated web-based tools to facilitate the use of such tools have not yet been developed.ResultsWe present two web tools for base editors, named BE-Designer and BE-Analyzer. BE-Designer provides all possible base editor target sequences in a given input DNA sequence with useful information including potential off-target sites. BE-Analyzer, a tool for assessing base editing outcomes from next generation sequencing (NGS) data, provides information about mutations in a table and interactive graphs. Furthermore, because the tool runs client-side, large amounts of targeted deep sequencing data (< 1 GB) do not need to be uploaded to a server, substantially reducing running time and increasing data security. BE-Designer and BE-Analyzer can be freely accessed at http://www.rgenome.net/be-designer/ and http://www.rgenome.net/be-analyzer/, respectively.ConclusionWe develop two useful web tools to design target sequence (BE-Designer) and to analyze NGS data from experimental results (BE-Analyzer) for CRISPR base editors.

biochemical research methods,biotechnology & applied microbiology,mathematical & computational biology
An Episomal CRISPR/Cas12a System for Mediating Efficient Gene Editing

Nannan Duan,Shuqing Tang,Baitao Zeng,Zhiqing Hu,Qian Hu,Lingqian Wu,Miaojin Zhou,Desheng Liang

DOI: https://doi.org/10.3390/life11111262

2021-11-18

Life

Abstract:(1) Background: Gene editing technology, as represented by CRISPR is a powerful tool used in biomedical science. However, the editing efficiency of such technologies, especially in induced pluripotent stem cells (iPSCs) and other types of stem cells, is low which hinders its application in regenerative medicine; (2) Methods: A gene-editing system, COE, was designed and constructed based on CRISPR/Cas12a and Orip/EBNA1, and its editing efficiency was evaluated in human embryonic kidney 293T (HEK-293T) cells with flow cytometry and restriction fragment length polymorphism (RFLP) analysis. The COE was nucleofected into iPSCs, then, the editing efficiency was verified by a polymerase chain reaction and Sanger sequencing; (3) Results: With the extension of time, COE enables the generation of up to 90% insertion or deletion rates in HEK-293T cells. Furthermore, the deletion of a 2.5 kb fragment containing Exon 51 of the dystrophin gene (DMD) in iPSCs was achieved with high efficiency; out of 14 clones analyzed, 3 were positive. Additionally, the Exon 51-deleted iPSCs derived from cardiomyocytes had similar expression profiles to those of Duchenne muscular dystrophy (DMD) patient-specific iPSCs. Moreover, there was no residue of each component of the plasmid in the editing cells; (4) Conclusions: In this study, a novel, efficient, and safe gene-editing system, COE, was developed, providing a powerful tool for gene editing.
Design of highly functional genome editors by modeling the universe of CRISPR-Cas sequences

Jeffrey A. Ruffolo,Stephen Nayfach,Joseph Gallagher,Aadyot Bhatnagar,Joel Beazer,Riffat Hussain,Jordan Russ,Jennifer Yip,Emily Hill,Martin Pacesa,Alexander J. Meeske,Peter Cameron,Ali Madani

DOI: https://doi.org/10.1101/2024.04.22.590591

2024-04-22

Abstract:Gene editing has the potential to solve fundamental challenges in agriculture, biotechnology, and human health. CRISPR-based gene editors derived from microbes, while powerful, often show significant functional tradeoffs when ported into non-native environments, such as human cells. Artificial intelligence (AI) enabled design provides a powerful alternative with potential to bypass evolutionary constraints and generate editors with optimal properties. Here, using large language models (LLMs) trained on biological diversity at scale, we demonstrate the first successful precision editing of the human genome with a programmable gene editor designed with AI. To achieve this goal, we curated a dataset of over one million CRISPR operons through systematic mining of 26 terabases of assembled genomes and meta-genomes. We demonstrate the capacity of our models by generating 4.8x the number of protein clusters across CRISPR-Cas families found in nature and tailoring single-guide RNA sequences for Cas9-like effector proteins. Several of the generated gene editors show comparable or improved activity and specificity relative to SpCas9, the prototypical gene editing effector, while being 400 mutations away in sequence. Finally, we demonstrate an AI-generated gene editor, denoted as OpenCRISPR-1, exhibits compatibility with base editing. We release OpenCRISPR-1 publicly to facilitate broad, ethical usage across research and commercial applications.

Synthetic Biology
EditR: A novel base editing quantification software using Sanger sequencing

Mitchell G. Kluesner,Derek A. Nedveck,Walker S. Lahr,John R. Garbe,Juan E. Abrahante,Beau R. Webber,Branden S. Moriarity

DOI: https://doi.org/10.1101/213496

2017-11-05

Abstract:ABSTRACT CRISPR/Cas9-Cytidine deaminase fusion enzymes - termed Base Editors – allow targeted editing of genomic deoxcytidine to deoxthymidine (C→T) without the need for double stranded break induction. Base editors represent a paradigm-shift in gene editing technology, due to their unprecedented efficiency to mediate targeted, single-base conversion; however, current analysis of base editing outcomes rely on methods that are either imprecise or expensive and time consuming. To overcome these limitations, we developed a simple, cost effective, and accurate program to measure base editing efficiency from fluorescence-based Sanger sequencing, termed EditR. We provide EditR as a free online tool or downloadable desktop application requiring a single Sanger sequencing file and guide RNA sequence ( baseeditr.com ). EditR is more accurate than enzymatic assays, and provides added insight to the position, type and efficiency of base editing. Collectively, we demonstrate that EditR is a robust, inexpensive tool that will facilitate the broad application of base editing technology, thereby fostering further innovation in this burgeoning field.
Development and application of CRISPR/Cas9 technologies in genomic editing.

Cui Zhang,Renfu Quan,Jinfu Wang

DOI: https://doi.org/10.1093/hmg/ddy120

IF: 5.1214

2018-01-01

Human Molecular Genetics

Abstract:Genomic editing to correct disease-causing mutations is a promising approach for the treatment of human diseases. As a simple and programmable nuclease-based genomic editing tool, the clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) system has substantially improved the ability to make precise changes in the human genome. Rapid development of CRISPR-based technologies in recent years has expanded its application scope and promoted CRISPR-based therapies in preclinical trails. Here, we review the application of the CRISPR system over the last 2 years; including its development and application in base editing, transcription modulation and epigenetic editing, genomic-scale screening, and cell and embryo therapy. Finally, the prospects and challenges related to application of CRISPR/Cas9 technologies are discussed.
CRISPR single base-editing: in silico predictions to variant clonal cell lines

Kristie-Ann Dickson,Natisha Field,Tiane Blackman,Yue Ma,Tao Xie,Ecem Kurangil,Sobia Idrees,Senani N H Rathnayake,Rashad M Mahbub,Alen Faiz,Deborah J Marsh

DOI: https://doi.org/10.1093/hmg/ddad105

IF: 5.1214

2023-06-28

Human Molecular Genetics

Abstract:Engineering single base edits using CRISPR technology including specific deaminases and single-guide RNA (sgRNA) is a rapidly evolving field. Different types of base edits can be constructed, with cytidine base editors (CBEs) facilitating transition of C-to-T variants, adenine base editors (ABEs) enabling transition of A-to-G variants, C•G-to-G•C transversion base editors (CGBEs) and recently adenine transversion editors (AYBE) that create A-to-C and A-to-T variants. The base-editing machine learning algorithm BE-Hive predicts which sgRNAs and base editor constructs have the strongest likelihood of achieving desired base edits. We have used BE-Hive and TP53 mutation data from The Cancer Genome Atlas ovarian cancer cohort to predict which mutations can be engineered, or reverted to wild-type sequence, using CBEs, ABEs or CGBEs. We have developed and automated a ranking system to assist in selecting optimally designed sgRNA that considers the presence of a suitable protospacer adjacent motif (PAM), the frequency of predicted bystander edits, editing efficiency and target base change. We have generated single constructs containing ABE or CBE editing machinery, an sgRNA cloning backbone and an enhanced green fluorescent protein tag (EGFP), removing the need for co-transfection of multiple plasmids. We have tested our ranking system and new plasmid constructs to engineer the p53 mutants Y220C, R282W and R248Q into wild-type p53 cells and shown that these mutants cannot activate four p53 target genes, mimicking the behaviour of endogenous p53 mutations. This field will continue to rapidly progress, requiring new strategies such as we propose to ensure desired base-editing outcomes.

genetics & heredity,biochemistry & molecular biology
Rational Design of Enhanced Nme2Cas9 and Nme2 Cas9 Nucleases and Base Editors

Nathan Bamidele,Aditya Ansodaria,Zexiang Chen,Haoyang Cheng,Rebecca Panwala,Eva Jazbec,Erik J. Sontheimer

DOI: https://doi.org/10.1101/2024.10.30.620986

2024-11-07

Abstract:CRISPR-Cas genome editing tools enable precise, RNA-guided modification of genomes within living cells. The most clinically advanced genome editors are Cas9 nucleases, but many nuclease technologies provide only limited control over genome editing outcomes. Adenine base editors (ABEs) and cytosine base editors (CBEs) enable precise and efficient nucleotide conversions of A:T-to-G:C and C:G-to-T:A base pairs, respectively. Therapeutic use of base editors (BEs) provides an avenue to correct approximately 30% of human pathogenic variants. Nonetheless, factors such as protospacer adjacent motif (PAM) availability, accuracy, product purity, and delivery limit the full therapeutic potential of BEs. We previously developed Nme2Cas9 and its BE derivatives, including ABEs compatible with single adeno-associated virus (AAV) vector delivery, in part to enable editing near N CC PAMs. Further engineering yielded domain-inlaid BEs with enhanced activity, as well as Nme2Cas9/SmuCas9 chimeras that target single-cytidine (N C) PAMs. Here we further enhance Nme2Cas9 and Nme2 Cas9 editing effectors for improved efficiency and vector compatibility through site-directed mutagenesis and deaminase linker optimization. Finally, we define the editing and specificity profiles of the resulting variants by using paired guide-target libraries.

Molecular Biology
SynDesign: web-based prime editing guide RNA design and evaluation tool for saturation genome editing

Jinman Park,Goosang Yu,Sang-Yeon Seo,Jinyeong Yang,Hyongbum Henry Kim

DOI: https://doi.org/10.1093/nar/gkae304

IF: 14.9

2024-04-30

Nucleic Acids Research

Abstract:Saturation genome editing (SGE) enables in-depth functional evaluation of disease-associated genes and variants by generating all possible single nucleotide variants (SNVs) within a given coding region. Although prime editing can be employed for inducing these SNVs, designing efficient prime editing guide RNAs (pegRNAs) can be challenging and time-consuming. Here, we present SynDesign, an easy-to-use webtool for the design, evaluation, and construction precision pegRNA libraries for SGE with synonymous mutation markers. SynDesign offers a simple yet powerful interface that automates the generation of all feasible pegRNA designs for a target gene or variant of interest. The pegRNAs are selected using the state-of-the-art models to predict prime editing efficiencies for various prime editors and cell types. Top-scoring pegRNA designs are further enhanced using synonymous mutation markers which improve pegRNA efficiency by diffusing the cellular mismatch repair mechanism and serve as sequence markers for improved identification of intended edits following deep sequencing. SynDesign is expected to facilitate future research using SGE to investigate genes or variants of interest associated with human diseases. SynDesign is freely available at https://deepcrispr.info/SynDesign without a login process.

biochemistry & molecular biology
Crispr-Based Editing of Human Pluripotent Stem Cells for Disease Modeling

Yun Chang,Feng Lan,Yongshuai Zhang,Shuhong Ma

DOI: https://doi.org/10.1007/s12015-024-10713-7

2024-04-03

Stem Cell Reviews and Reports

Abstract:The CRISPR system, as an effective genome editing technology, has been extensively utilized for the construction of disease models in human pluripotent stem cells. Establishment of a gene mutant or knockout stem cell line typically relies on Cas nuclease-generated double-stranded DNA breaks and exogenous templates, which can produce uncontrollable editing byproducts and toxicity. The recently developed adenine base editors (ABE) have greatly facilitated related research by introducing A/T > G/C mutations in the coding regions or splitting sites (AG-GT) of genes, enabling mutant gene knock-in or knock-out without introducing DNA breaks. In this study, we edit the AG bases in exons anterior to achieve gene knockout via the ABE8e-SpRY, which recognizes most expanded protospacer adjacent motif to target the genome. Except for gene-knockout, ABE8e-SpRY can also efficiently establish disease-related A/T-to-G/C variation cell lines by targeting coding sequences. The method we generated is simple and time-saving, and it only takes two weeks to obtain the desired cell line. This protocol provides operating instructions step-by-step for constructing knockout and point mutation cell lines.

cell biology,medicine, research & experimental,cell & tissue engineering
CRISPER/CAS: A potential tool for genomes editing

DOI: https://doi.org/10.47262//bl/7.2.20210711

2021-11-12

Biomedical Letters

Abstract:The ability to engineer genomes presents a significant opportunity for applied biology research. In 2050, the population of this world is expected to reach 9.6 billion residents; rising food with better quality is the most promising approach to food security. Compared to earlier methodologies including Zinc Finger Nucleases (ZFNs) plus Transcription Activator-Like Effector Nucleases (TALENs), which were expensive as well as time-consuming, innovation in Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and related CRISPR (Cas) protein classifications allowed selective editing of genes for the enhancement of food. The basic mechanism of CRISPR Cas9 process and its applications on genome editing has been summarized in this manuscript. The method relies on Sequence-Specific Nucleases (SSNs) to create Double Stranded Breaks (DSB) of DNA at the locus of genome defined by user, mended by using one of two DNA mending ways: Non-Homologous End Joining (NHEJ) or Homology Directed Repair (HDR). Cas9, an RNA-guided endonuclease, was used to produce stable knock-in and knock-out mutants. The focus of this effort is to explore the CRISPR Cas9 genome editing to manage gene expression and improve future editing success. This adaptable technique can be consumed for a wide range of applications of genome editing requiring high precision. Advances in this technology have sparked renewed interest in the possibilities for editing genome in plants.
EditR: A Method to Quantify Base Editing from Sanger Sequencing

Mitchell G. Kluesner,Derek A. Nedveck,Walker S. Lahr,John R. Garbe,Juan E. Abrahante,Beau R. Webber,Branden S. Moriarity

DOI: https://doi.org/10.1089/crispr.2018.0014

2018-06-01

The CRISPR Journal

Abstract:CRISPR-Cas9-Cytidine deaminase fusion enzymes-termed "base editors"-allow targeted editing of genomic deoxycytidine to deoxythymidine (C:G→T:A) without the need for double-stranded break induction. Base editors represent a paradigm shift in gene editing technology due to their unprecedented efficiency to mediate targeted, single-base conversion. However, current analysis of base editing outcomes rely on methods that are either imprecise or expensive and time-consuming. To overcome these limitations, we developed a simple, cost-effective, and accurate program to measure base editing efficiency from fluorescence-based Sanger sequencing, termed "EditR." We provide EditR as a free online tool or downloadable desktop application requiring a single Sanger sequencing file and guide RNA sequence. EditR is more accurate than enzymatic assays, and provides added insight to the position, type, and efficiency of base editing. Furthermore, EditR is likely amenable to quantify base editing from the recently developed adenosine deaminase base editors that act on either DNA (adenosine deaminase base editors [ABEs]) or RNA (REPAIRs) (catalyzes A:T→G:C). Collectively, we demonstrate that EditR is a robust, inexpensive tool that will facilitate the broad application of base editing technology, thereby fostering further innovation in this burgeoning field.

genetics & heredity
The Development and Application of a Base Editor in Biomedicine

Fang Wang,Yuqiang Zeng,Yi Wang,Yuyu Niu

DOI: https://doi.org/10.1155/2020/2907623

2020-01-01

BioMed Research International

Abstract:Using a base editor to generate monogenic disease models and correct pathogenic point mutations is a breakthrough technology for exploration and treatment of human diseases. As a burgeoning approach for genomic modification, the fused CRISPR/Cas9 with various deaminase separately has significantly increased the efficiency of producing a precise point mutation with minimal insertions or deletions (indels). Along with the flexibility and efficiency, a base editor has been widely used in many fields. This review discusses the recent development of a base editor, including evolution and advance, and highlights the applications and challenges in the field of gene therapy. Depending on rapid improvement and optimization of gene editing technology, the prospect of base editor is immeasurable.
A quick guide to CRISPR sgRNA design tools

Vincent A Brazelton,Scott Zarecor,David A Wright,Yuan Wang,Jie Liu,Keting Chen,Bing Yang,Carolyn J Lawrence-Dill

DOI: https://doi.org/10.1080/21645698.2015.1137690

2015-10-02

Abstract:Targeted genome editing is now possible in nearly any organism and is widely acknowledged as a biotech game-changer. Among available gene editing techniques, the CRISPR-Cas9 system is the current favorite because it has been shown to work in many species, does not necessarily result in the addition of foreign DNA at the target site, and follows a set of simple design rules for target selection. Use of the CRISPR-Cas9 system is facilitated by the availability of an array of CRISPR design tools that vary in design specifications and parameter choices, available genomes, graphical visualization, and downstream analysis functionality. To help researchers choose a tool that best suits their specific research needs, we review the functionality of various CRISPR design tools including our own, the CRISPR Genome Analysis Tool (CGAT; http://cropbioengineering.iastate.edu/cgat ).
The pathology of Plasmodium falciparum in owl monkeys.

D. Ridley,A. Voller,W. Richards

Transactions of the Royal Society of Tropical Medicine and Hygiene

Abstract:
An in situ cut-and-paste genome editing platform mediated by CRISPR/Cas9 or Cas12a

Ping Jiang,Kevin M. Kemper,Kai-Ti Chang,Cheng Qian,Yulong Li,Liying Guan,Peter van Hasselt,Salvatore J. Caradonna,Randy Strich

DOI: https://doi.org/10.1101/2022.03.30.486486

2022-03-31

Abstract:ABSTRACT Recombinant DNA technology mediated by restriction enzymes and ligases allows in vitro manipulation of a DNA segment isolated from the genome. Short overhangs generated by restriction enzymes facilitate efficient pasting together a DNA sequence and a vector. We adopted this recombinant DNA strategy to develop an in vivo recombinant-genome genome editing approach. Using the programmable endonuclease Cas9 or Cas12a as a restriction enzyme, we devised an in situ c ut- a nd- p aste (iCAP) genome editing method that was tested in both mouse germline and human cell line platforms. Mouse gene loci Slc35f2 and Slc35f6 were each edited with in-frame insertion of a large APEX2-Cre cassette and concurrent FRT3 insertion at a second location providing proof of principle for the iCAP method. Further, a de nova single nucleotide mutation associated with MED13L syndrome was efficiently corrected in patient cells. Altogether, the iCAP method provides a single genome editing platform with flexibility and multiutility enabling versatile and precise sequence alterations, such as insertion, substitution, and deletion, at single or multiple locations within a genomic segment in mammalian genomes.
CRISPR-GPT: An LLM Agent for Automated Design of Gene-Editing Experiments

Kaixuan Huang,Yuanhao Qu,Henry Cousins,William A. Johnson,Di Yin,Mihir Shah,Denny Zhou,Russ Altman,Mengdi Wang,Le Cong

2024-04-28

Abstract:The introduction of genome engineering technology has transformed biomedical research, making it possible to make precise changes to genetic information. However, creating an efficient gene-editing system requires a deep understanding of CRISPR technology, and the complex experimental systems under investigation. While Large Language Models (LLMs) have shown promise in various tasks, they often lack specific knowledge and struggle to accurately solve biological design problems. In this work, we introduce CRISPR-GPT, an LLM agent augmented with domain knowledge and external tools to automate and enhance the design process of CRISPR-based gene-editing experiments. CRISPR-GPT leverages the reasoning ability of LLMs to facilitate the process of selecting CRISPR systems, designing guide RNAs, recommending cellular delivery methods, drafting protocols, and designing validation experiments to confirm editing outcomes. We showcase the potential of CRISPR-GPT for assisting non-expert researchers with gene-editing experiments from scratch and validate the agent's effectiveness in a real-world use case. Furthermore, we explore the ethical and regulatory considerations associated with automated gene-editing design, highlighting the need for responsible and transparent use of these tools. Our work aims to bridge the gap between beginner biological researchers and CRISPR genome engineering techniques, and demonstrate the potential of LLM agents in facilitating complex biological discovery tasks.

Artificial Intelligence,Computation and Language,Human-Computer Interaction,Quantitative Methods
AutoESDCas: A Web-Based Tool for the Whole-Workflow Editing Sequence Design for Microbial Genome Editing Based on the CRISPR/Cas System

Chunhe Yang,Yi Yang,Guangyun Chu,Ruoyu Wang,Haoran Li,Yufeng Mao,Meng Wang,Jian Zhang,Xiaoping Liao,Hongwu Ma

DOI: https://doi.org/10.1021/acssynbio.4c00063

IF: 5.249

2024-06-08

ACS Synthetic Biology

Abstract:Genome editing is the basis for the modification of engineered microbes. In the process of genome editing, the design of editing sequences, such as primers and sgRNA, is very important for the accurate positioning of editing sites and efficient sequence editing. The whole process of genome editing involves multiple rounds and types of editing sequence design, while the development of related whole-workflow design tools for high-throughput experimental requirements lags. Here, we propose...

biochemical research methods
GEDpm-cg: Genome Editing Automated Design Platform for Point Mutation Construction in Corynebacterium glutamicum

Yi Yang,Yufeng Mao,Ye Liu,Ruoyu Wang,Hui Lu,Haoran Li,Jiahao Luo,Meng Wang,Xiaoping Liao,Hongwu Ma

DOI: https://doi.org/10.3389/fbioe.2021.768289

IF: 5.7

2021-10-15

Frontiers in Bioengineering and Biotechnology

Abstract:Advances in robotic system-assisted genome editing techniques and computer-aided design tools have significantly facilitated the development of microbial cell factories. Although multiple separate software solutions are available for vector DNA assembly, genome editing, and verification, by far there is still a lack of complete tool which can provide a one-stop service for the entire genome modification process. This makes the design of numerous genetic modifications, especially the construction of mutations that require strictly precise genetic manipulation, a laborious, time-consuming and error-prone process. Here, we developed a free online tool called GEDpm-cg for the design of genomic point mutations in C. glutamicum . The suicide plasmid-mediated counter-selection point mutation editing method and the overlap-based DNA assembly method were selected to ensure the editability of any single nucleotide at any locus in the C. glutamicum chromosome. Primers required for both DNA assembly of the vector for genetic modification and sequencing verification were provided as design results to meet all the experimental needs. An in-silico design task of over 10,000 single point mutations can be completed in 5 min. Finally, three independent point mutations were successfully constructed in C. glutamicum guided by GEDpm-cg, which confirms that the in-silico design results could accurately and seamlessly be bridged with in vivo or in vitro experiments. We believe this platform will provide a user-friendly, powerful and flexible tool for large-scale mutation analysis in the industrial workhorse C. glutamicum via robotic/software-assisted systems.

multidisciplinary sciences
Enhanced guide-RNA design and targeting analysis for precise CRISPR genome editing of single and consortia of industrially relevant and non-model organisms

Brian J Mendoza,Cong T Trinh

DOI: https://doi.org/10.1093/bioinformatics/btx564

IF: 5.8

2017-09-08

Bioinformatics

Abstract:Motivation: Genetic diversity of non-model organisms offers a repertoire of unique phenotypic features for exploration and cultivation for synthetic biology and metabolic engineering applications. To realize this enormous potential, it is critical to have an efficient genome editing tool for rapid strain engineering of these organisms to perform novel programmed functions.Results: To accommodate the use of CRISPR/Cas systems for genome editing across organisms, we have developed a novel method, named CRISPR Associated Software for Pathway Engineering and Research (CASPER), for identifying on- and off-targets with enhanced predictability coupled with an analysis of non-unique (repeated) targets to assist in editing any organism with various endonucleases. Utilizing CASPER, we demonstrated a modest 2.4% and significant 30.2% improvement (F-test, P < 0.05) over the conventional methods for predicting on- and off-target activities, respectively. Further we used CASPER to develop novel applications in genome editing: multitargeting analysis (i.e. simultaneous multiple-site modification on a target genome with a sole guide-RNA requirement) and multispecies population analysis (i.e. guide-RNA design for genome editing across a consortium of organisms). Our analysis on a selection of industrially relevant organisms revealed a number of non-unique target sites associated with genes and transposable elements that can be used as potential sites for multitargeting. The analysis also identified shared and unshared targets that enable genome editing of single or multiple genomes in a consortium of interest. We envision CASPER as a useful platform to enhance the precise CRISPR genome editing for metabolic engineering and synthetic biology applications.Availability and implementation: https://github.com/TrinhLab/CASPER.Contact: ctrinh@utk.edu.Supplementary information: Supplementary data are available at Bioinformatics online.

biochemical research methods,biotechnology & applied microbiology,mathematical & computational biology
Crispr-Era: A Comprehensive Design Tool for Crispr-Mediated Gene Editing, Repression and Activation

Honglei Liu,Zheng Wei,Antonia Dominguez,Yanda Li,Xiaowo Wang,Lei S. Qi

DOI: https://doi.org/10.1093/bioinformatics/btv423

IF: 5.8

2015-01-01

Bioinformatics

Abstract:A Summary: The CRISPR/Cas9 system was recently developed as a powerful and flexible technology for targeted genome engineering, including genome editing (altering the genetic sequence) and gene regulation (without altering the genetic sequence). These applications require the design of single guide RNAs (sgRNAs) that are efficient and specific. However, this remains challenging, as it requires the consideration of many criteria. Several sgRNA design tools have been developed for gene editing, but currently there is no tool for the design of sgRNAs for gene regulation. With accumulating experimental data on the use of CRISPR/Cas9 for gene editing and regulation, we implement a comprehensive computational tool based on a set of sgRNA design rules summarized from these published reports. We report a genome-wide sgRNA design tool and provide an online website for predicting sgRNAs that are efficient and specific. We name the tool CRISPR-ERA, for clustered regularly interspaced short palindromic repeat-mediated editing, repression, and activation (ERA).

Whole exome sequencing is an efficient, sensitive and specific method of mutation detection in osteogenesis imperfecta and Marfan syndrome.

Web-based design and analysis tools for CRISPR base editing

An Episomal CRISPR/Cas12a System for Mediating Efficient Gene Editing

Design of highly functional genome editors by modeling the universe of CRISPR-Cas sequences

EditR: A novel base editing quantification software using Sanger sequencing

Development and application of CRISPR/Cas9 technologies in genomic editing.

CRISPR single base-editing: in silico predictions to variant clonal cell lines

Rational Design of Enhanced Nme2Cas9 and Nme2 Cas9 Nucleases and Base Editors

SynDesign: web-based prime editing guide RNA design and evaluation tool for saturation genome editing

Crispr-Based Editing of Human Pluripotent Stem Cells for Disease Modeling

CRISPER/CAS: A potential tool for genomes editing

EditR: A Method to Quantify Base Editing from Sanger Sequencing

The Development and Application of a Base Editor in Biomedicine

A quick guide to CRISPR sgRNA design tools

The pathology of Plasmodium falciparum in owl monkeys.

An in situ cut-and-paste genome editing platform mediated by CRISPR/Cas9 or Cas12a

CRISPR-GPT: An LLM Agent for Automated Design of Gene-Editing Experiments

AutoESDCas: A Web-Based Tool for the Whole-Workflow Editing Sequence Design for Microbial Genome Editing Based on the CRISPR/Cas System

GEDpm-cg: Genome Editing Automated Design Platform for Point Mutation Construction in Corynebacterium glutamicum

Enhanced guide-RNA design and targeting analysis for precise CRISPR genome editing of single and consortia of industrially relevant and non-model organisms

Crispr-Era: A Comprehensive Design Tool for Crispr-Mediated Gene Editing, Repression and Activation